Earlier this week, the Drug Enforcement Administration (DEA) held a preliminary hearing as part of the ongoing process to determine whether cannabis should be reclassified from Schedule I to Schedule III of the Controlled...more
Last week, Governor Phil Murphy signed into law Senate Bill No. 3235—a bill temporarily banning the unlicensed sale of hemp products in New Jersey and proposing a new regulatory framework for future sales. The law, which is...more
In a landmark move, New Jersey’s Senate Health, Human Services, and Senior Citizens Committee convened on June 6 to deliberate on the Psilocybin Behavioral Health Access and Services Act, a groundbreaking bill with the...more
Earlier this week, the Department of Justice proposed reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. The move follows an August 2023 recommendation from the Department of Health...more
5/6/2024
/ Agribusiness ,
Banks ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Financial Services Industry ,
FinCEN ,
Food and Drug Administration (FDA) ,
Internal Revenue Code (IRC) ,
Know Your Customers ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
NIDA ,
Popular ,
Schedule I Drugs
Yesterday’s meeting of the New Jersey Assembly Oversight, Reform, and Federal Relations Committee provided new insights into the New Jersey cannabis industry and highlighted several developments which give cause for optimism...more